$124.83+16.13% · 3M
Moving avg
1W+12.56%
1M+13.44%
3M+16.13%
6M+10.05%
YTD+17.35%
1Y+5.23%
3Y+73.83%
5Y+101.24%
52-week range
$92.7791% of range$127.99
Company health
Value4/6
Growth4/6
Profitability4/6
Health2/6
Dividend4/6
Bull vs bear
Strengths
- Analysts see 17% upside to a $146 target
- Analyst consensus is "Buy"
- High return on equity (2535%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$12.38B
Enterprise value
$13.64B
P/E ratio (TTM)
18.27x
P/S ratio (TTM)
1.82x
EV/EBITDA
9.33x
Per share & returns
EPS (TTM)
$6.14
Dividend yield
0.68%
Beta (1Y)
0.60
30-day change
+13.44%
Trading
Volume (24h)
951.12K
Previous close
$125.35
Shares outstanding
99.20M
About Encompass Health Corporation
Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NYSE
Symbol
EHC
Encompass Health Corporation is a large-cap healthcare company in the Medical - Care Facilities industry. Its shares are listed on NYSE (United States) and trade under the ticker EHC.
Frequently asked questions
What is Encompass Health Corporation's market cap?
Encompass Health Corporation (EHC) has a market capitalization of $12.38B.
What is Encompass Health Corporation's P/E ratio?
Encompass Health Corporation trades at a price-to-earnings (P/E) ratio of 18.27.
What exchange does EHC trade on?
EHC trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.12B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap